Search Results - "Kirchberg, Janine"
-
1
-
2
Aconitase B is required for optimal growth of Xanthomonas campestris pv. vesicatoria in pepper plants
Published in PloS one (06-04-2012)“…The aerobic plant pathogenic bacterium Xanthomonas campestris pv. vesicatoria (Xcv) colonizes the intercellular spaces of pepper and tomato. One enzyme that…”
Get full text
Journal Article -
3
Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
Published in Journal of the American College of Cardiology (18-10-2022)“…BACKGROUNDClonal hematopoiesis of indeterminate potential (CHIP) is common in elderly individuals and is associated with an increased risk of both hematologic…”
Get full text
Journal Article -
4
Apheresis for Production of Chimeric Antigen Receptor (CAR) T Cells in Patients with Multiple Myeloma - Clinical Factors, Cell Composition and T Cell Senescence
Published in Blood (02-11-2023)“…Chimeric antigen receptor (CAR) T cells have been proven as a highly promising immunotherapy for patients with multiple myeloma (MM). Apheresis of autologous…”
Get full text
Journal Article -
5
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
Published in Leukemia (01-02-2024)“…B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T cells revolutionized the treatment of relapsed/refractory multiple myeloma (RRMM)…”
Get full text
Journal Article -
6
Cellular Dynamics Following CAR T Cell Therapy Are Associated with Response, Resistance and Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma
Published in Blood (02-11-2023)“…Introduction The introduction of B cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T cells revolutionized the treatment of…”
Get full text
Journal Article -
7
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Anti-BCMA-directed chimeric antigen receptor (CAR) T cells are effective treatment for patients with refractory/relapsed multiple myeloma (RRMM). However,…”
Get full text
Journal Article